3-LGD (LGD-3303) | GENETIXX LABORATORIES

3-LGD (formerly known as L3303 by Matrix Labs)

3-LGD contains LGD-3303, a compound commonly referenced in research environments for its interaction with androgen receptors located primarily in skeletal muscle tissue.

LGD-3303 has been explored in scientific literature in relation to muscle-related signalling pathways, strength-focused environments, and performance-oriented research settings.

Due to its interaction with androgen-related pathways, LGD-3303 has been discussed in research investigating lean tissue signalling, muscle development processes, and physical performance markers.

3-LGD provides a structured capsule format designed for controlled laboratory environments examining androgen receptor activity.

---

Research Focus

In research environments, LGD-3303 is commonly explored in relation to:

• Muscle development pathways
• Skeletal muscle signalling processes
• Strength and performance related markers
• Androgen receptor interaction in muscle tissue
• Lean tissue signalling environments

LGD-3303 is frequently referenced within research involving androgen receptor modulation and performance-focused compound evaluation.

---

Compound Profile

LGD-3303

LGD-3303 is a compound studied for its interaction with androgen receptors, particularly in skeletal muscle tissue.

Research literature has explored its association with muscle-related signalling pathways, performance-focused environments, and lean tissue development processes.

---

Product Format

Caps per container: 60

2 capsules contain:

3-LGD – 20mg total

• LGD-3303

Other ingredients:
Gelatin (capsule), Magnesium Stearate, Silicon Dioxide

---

Why 3-LGD

LGD-3303 is a compound frequently discussed in research involving androgen receptor interaction and muscle-related signalling pathways.

3-LGD provides a consistent capsule formulation designed for laboratory environments investigating structured performance and receptor-focused research models.